다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

OKYO

OKYO Pharma (OKYO)

OKYO Pharma Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:OKYO

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/11/26	21:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OKYO	OKYO Pharma Ltd
2024/11/26	21:00	GlobeNewswire Inc.	OKYO Pharma to Participate at the 4th Annual BTIG Ophthalmology Conference	NASDAQ:OKYO	OKYO Pharma Ltd
2024/10/30	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OKYO	OKYO Pharma Ltd
2024/10/30	20:00	GlobeNewswire Inc.	OKYO Pharma to Present at International Tear Film and Ocular Surface Society Conference	NASDAQ:OKYO	OKYO Pharma Ltd
2024/10/23	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OKYO	OKYO Pharma Ltd
2024/10/23	20:00	GlobeNewswire Inc.	OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain	NASDAQ:OKYO	OKYO Pharma Ltd
2024/10/16	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OKYO	OKYO Pharma Ltd
2024/10/16	20:00	GlobeNewswire Inc.	OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain	NASDAQ:OKYO	OKYO Pharma Ltd
2024/09/10	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OKYO	OKYO Pharma Ltd
2024/09/10	20:00	GlobeNewswire Inc.	OKYO Pharma Announces Chairman Acquires Shares	NASDAQ:OKYO	OKYO Pharma Ltd
2024/09/05	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OKYO	OKYO Pharma Ltd
2024/09/05	20:00	GlobeNewswire Inc.	OKYO Pharma Announces Chairman Acquires Shares	NASDAQ:OKYO	OKYO Pharma Ltd
2024/08/27	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OKYO	OKYO Pharma Ltd
2024/08/27	20:00	GlobeNewswire Inc.	OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease	NASDAQ:OKYO	OKYO Pharma Ltd
2024/08/23	22:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OKYO	OKYO Pharma Ltd
2024/08/23	22:00	GlobeNewswire Inc.	OKYO Pharma CEO Interview to Air on Bloomberg TV	NASDAQ:OKYO	OKYO Pharma Ltd
2024/08/23	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OKYO	OKYO Pharma Ltd
2024/08/23	20:00	GlobeNewswire Inc.	OKYO Pharma Announces Chairman Acquires Shares	NASDAQ:OKYO	OKYO Pharma Ltd
2024/08/21	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OKYO	OKYO Pharma Ltd
2024/08/21	20:00	GlobeNewswire Inc.	OKYO Pharma Announces Chairman Acquires Shares	NASDAQ:OKYO	OKYO Pharma Ltd
2024/08/16	02:21	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OKYO	OKYO Pharma Ltd
2024/08/16	01:13	GlobeNewswire Inc.	OKYO Pharma Participates in H.C. Wainwright 4th Annual Ophthalmology Virtual Conference	NASDAQ:OKYO	OKYO Pharma Ltd
2024/08/14	05:30	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:OKYO	OKYO Pharma Ltd
2024/08/06	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OKYO	OKYO Pharma Ltd
2024/08/06	20:00	GlobeNewswire Inc.	OKYO Pharma Granted European Patent Covering OK-101 Chemerin Analogs and Their Method of Use	NASDAQ:OKYO	OKYO Pharma Ltd
2024/08/01	06:00	Edgar (US Regulatory)	Form NT 20-F - Notification of inability to timely file Form 20-F	NASDAQ:OKYO	OKYO Pharma Ltd
2024/07/11	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OKYO	OKYO Pharma Ltd
2024/07/11	20:00	GlobeNewswire Inc.	OKYO Pharma to Initiate Neuropathic Corneal Pain Trial for OK-101	NASDAQ:OKYO	OKYO Pharma Ltd
2024/07/10	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OKYO	OKYO Pharma Ltd
2024/07/10	20:00	GlobeNewswire Inc.	OKYO Pharma Announces Promising Categorical Data from OK-101 Phase 2 Trial in Dry Eye Disease	NASDAQ:OKYO	OKYO Pharma Ltd

검색 관련기사 보기:NASDAQ:OKYO

1 2 3 4 5 6 다음 >>

US Dollar vs Yen

Gold vs US Dollar

Verizon Communications

US Dollar vs Euro

US Dollar vs Sterling

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관